CClinicalTrials.gg
Sign In
Status unknownNCT01196962Updated Nov 27, 2012

Safety Study of Subclavian and Internal Jugular Venous Catheterization

An interventional study of Central venous catheter in Time to Insertion and Rates of Complications, sponsored by E-DA Hospital. Status unknown at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2012-11-27.

Sponsored by E-DA Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2011), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
20 Years and older
Sex
All
01

Study summary

There is no randomized controlled trial to compare the rates of complications associated with internal jugular and subclavian venous catheterization. The aim of this study is to compare mechanical, infectious, and thrombotic complications of internal jugular and subclavian venous catheterization. An improved understanding of CVC-related risks might help clinicians to choose one approach over the other in specific clinical settings.

Read the detailed description

Central venous catheterization is often necessary to treat critically ill patients hospitalized in intensive care units (ICUs). However, this procedure may lead to serious and sometimes life-threatening complications, including mechanical, infectious, or thrombotic complications. The choice of insertion site can influence the incidence and type of such complications. The most frequently used sites for CVC insertion are the internal jugular and the subclavian vein. However, in an individual patient, criteria for choosing one approach over the other remain unclear.

02

Conditions studied

  • Time to Insertion
  • Rates of Complications

Keywords

  • central venous catheter
  • complications
  • internal jugular vein
  • randomized trial
  • subclavian vein
03

In context

Lead sponsor

E-DA Hospital is the lead sponsor of 34 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • admission to ICU
  • requiring central venous catheterization
  • without contraindications to attempt both jugular and internal jugular access

Exclusion criteria

Exclusion Criteria:

  • the presence of a central venous catheter at admission
  • central venous catheterization within 2 weeks prior to admission
  • emergency catheterization for a life-threatening situation
  • major blood coagulation disorders
  • anatomic defect precluding catheterization at either site
  • skin lesions or recent surgery at either site
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    Internal jugular vein

    Device: Central venous catheter

Interventions

  • DeviceCentral venous catheter

    Central venous catheter insertion to subclavian vein

    Also known as: venous access

06

What researchers measure

Primary outcomes

  1. Time to completely insertion

    Time frame: 1 hour

Secondary outcomes

  1. rates of mechanical, infectious, and thrombotic complications

    Time frame: 14 days

07

Study locations

1 of 1 sites recruiting
  • E-Da hospital
    Kaohsiung, 7, Taiwan
    • Yu-Feng Wei, M.D. · Contact · ed102746@edah.org.tw · +886-7-615-0011
    • Yu-Feng Wei, M.D. · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 27, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01196962
Lead sponsor
E-DA Hospital
Responsible party
Sponsor
First posted
Sep 9, 2010
Start date
Nov 2010
Primary completion
Dec 2013 (estimated)
Completion
Dec 2013 (estimated)
Last update
Nov 27, 2012

Study contacts

Yu-Feng Wei, M.D.
Contact
ed102746@edah.org.tw
+886-7-615-0011 ext. 2980
Yu-Feng Wei, M.D.
principal investigator · Chest department

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

E-DA Hospital

Start the discussion